• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

86.47 +0.57 (+0.66%)
Official Closing Price Updated: 7:00 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,172,766
Open 85.76
Bid (Size) 85.28 (100)
Ask (Size) 87.00 (200)
Prev. Close 85.90
Today's Range 85.20 - 86.95
52wk Range 65.94 - 87.89
Shares Outstanding 580,800,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
February 26, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
February 20, 2026
Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s... 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+1.3%
+1.3%
1 Month
+5.6%
+5.6%
3 Month
-0.2%
-0.2%
6 Month
+6.3%
+6.3%
1 Year
+21.1%
+21.1%

More News

Read More
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
February 19, 2026
Via MarketMinute
Edwards Lifesciences Corp (NYSE:EW) Reports Mixed Q4 Results, Misses EPS Estimates ↗
February 10, 2026
Via Chartmill
News headline image
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
February 19, 2026
From Edwards Lifesciences Corporation
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
February 17, 2026
Via Chartmill
News headline image
The Return of the Mega-Deal: How 2026’s Regulatory Pragmatism is Reshaping Corporate America
February 13, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
February 13, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗
February 12, 2026
Via MarketBeat
News headline image
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
February 12, 2026
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume S&P500 stocks in Wednesday's session ↗
February 11, 2026
Via Chartmill
News headline image
Edwards Lifesciences (EW) Earnings Transcript ↗
February 10, 2026
Via The Motley Fool
News headline image
Edwards Lifesciences Reports Fourth Quarter Results
February 10, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
February 05, 2026
Via MarketMinute
Topics Supply Chain
News headline image
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
February 03, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
February 02, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants
January 27, 2026
Via MarketMinute
News headline image
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗
January 25, 2026
Via MarketBeat
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
January 23, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Death of the Quick Deal: One Year Under the New FTC and DOJ Merger Regime
January 23, 2026
Via MarketMinute
Topics Economy
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
From Equity Insider
Via GlobeNewswire
News headline image
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
January 15, 2026
Via MarketMinute
Topics Artificial Intelligence
News headline image
Edwards Comments on JenaValve Acquisition
January 09, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
January 02, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The 2025 Dollar Rollercoaster: A Year-End Rally Masks a Historic Annual Retreat
December 31, 2025
Via MarketMinute
Topics Economy World Trade

Frequently Asked Questions

Is Edwards Lifesciences publicly traded?
Yes, Edwards Lifesciences is publicly traded.
What exchange does Edwards Lifesciences trade on?
Edwards Lifesciences trades on the New York Stock Exchange
What is the ticker symbol for Edwards Lifesciences?
The ticker symbol for Edwards Lifesciences is EW on the New York Stock Exchange
What is the current price of Edwards Lifesciences?
The current price of Edwards Lifesciences is 86.47
When was Edwards Lifesciences last traded?
The last trade of Edwards Lifesciences was at 02/27/26 07:00 PM ET
What is the market capitalization of Edwards Lifesciences?
The market capitalization of Edwards Lifesciences is 50.22B
How many shares of Edwards Lifesciences are outstanding?
Edwards Lifesciences has 50B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap